ArticleInternational journal of molecular sciences2024

The Vasopressin Receptor Antagonist Tolvaptan Counteracts Tumor Growth in a Murine Xenograft Model of Small Cell Lung Cancer.

Laura Naldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.